{
    "clinical_study": {
        "@rank": "87378", 
        "acronym": "EENM", 
        "arm_group": {
            "arm_group_label": "Group 1 (G1) NMES is applied in the spastic antagonist muscle", 
            "arm_group_type": "Experimental", 
            "description": "The parameters considered for the application of NMES are: frequency of 50Hz, the wavelength of 350m / s, 10 seconds of contraction of 20 seconds of rest to total 15 minutes. During the application of NMES patients will be positioned supine on the bed with knees flexed semi supported on roller positioning. The G1 apply NMES on the motor point of the tibialis anterior and triceps surae lengthening held along with the contraction (reciprocal inhibition)."
        }, 
        "brief_summary": {
            "textblock": "To evaluate and compare the effects of Neuromuscular Electrical Stimulation when applied in\n      the agonist and antagonist muscles of spastic hemiparetic patients.\n\n      The specific objectives are:\n\n        -  Evaluate the resistance movement, strength and muscle electrical activity before and\n           after application of Neuromuscular Electrical Stimulation in spastic muscle\n           (gastrocnemius).\n\n        -  Evaluate the resistance movement, strength and muscle electrical activity before and\n           after application of Neuromuscular Electrical Stimulation in the spastic antagonist\n           muscle (tibialis anterior).\n\n        -  Compare the risk of falls after application of Neuromuscular Electrical Stimulation in\n           both muscles studied."
        }, 
        "brief_title": "Analysis of the Electrical Muscle Activity and Resistance to Movement in Spastic Hemiparetic Patients.", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Cerebrovascular Accident", 
        "condition_browse": {
            "mesh_term": [
                "Paresis", 
                "Cerebral Infarction", 
                "Stroke"
            ]
        }, 
        "detailed_description": {
            "textblock": "Most hemiparetic patients can develop spasticity, characterized by neuronal\n      hyperexcitability, increased resistance to passive stretch, Babinski sign, clonus, reflexes\n      and involuntary spasms skin.\n\n      As a consequence, there may be contractures and muscle shortening, generating functional\n      limitations. Neuromuscular Electrical Stimulation feature that can control the spasticity\n      through reciprocal inhibition, muscle relaxation and sensory stimulation. The goal will be\n      to evaluate and compare the effects of neuromuscular electrical stimulation when applied in\n      the agonist and antagonist muscles of spastic hemiparetic patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  involve patients who have spasticity grade 1, 1 + and 2 of the gastrocnemius muscle,\n             which ambulate with or without assistance devices, patients who tolerate the stimulus\n             and have preserved cognition.\n\n        Exclusion Criteria:\n\n          -  involve patients who have severe shortening, joint stiffness, cognitive deficits and\n             patients with hypersensitivity."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945151", 
            "org_study_id": "03559712.6.0000.0077"
        }, 
        "intervention": {
            "arm_group_label": "Group 1 (G1) NMES is applied in the spastic antagonist muscle", 
            "description": "The G2 apply NMES in the gastrocnemius motor point and the rest will be done during stretching of the gastrocnemius muscle (autogenic inhibition). Five consecutive sessions will be held in the morning and afternoon in the laboratory of Sensory Motor Rehabilitation Engineering.", 
            "intervention_name": "Group 2 (G2) NMES is applied in the spastic muscle (gastrocnemius).", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "spastic hemiparesis", 
        "lastchanged_date": "September 13, 2013", 
        "location": {
            "contact": {
                "email": "s.takeshi@hotmail.com", 
                "last_name": "Sergio ST Takeshi, pesquisadora", 
                "phone": "55 12 8137-1012", 
                "phone_ext": "2066"
            }, 
            "facility": {
                "address": {
                    "city": "S\u00e3o Jos\u00e9 dos Campos", 
                    "country": "Brazil", 
                    "state": "S\u00e3o Paulo", 
                    "zip": "55"
                }, 
                "name": "Laborat\u00f3rio de Engenharia de Reabilita\u00e7\u00e3o Sensorio Motora"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "1", 
        "official_title": "Analysis of the Electrical Muscle Activity and Resistance to Movement After Pplication Neuromuscular Electrical Stimulation (EENM) in Patients With Hemiparesis Spastic.", 
        "overall_contact": {
            "email": "s.takeshi@hotmail.com", 
            "last_name": "Sergio ST Takeshi, pesquisadora", 
            "phone": "55 12 39947 1000", 
            "phone_ext": "2066"
        }, 
        "overall_official": {
            "affiliation": "Universidade do Vale do Para\u00edba", 
            "last_name": "Sergio ST Takeshi, pesquisador", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The G1 apply Neuromuscular Electrical Stimulation on the motor point of the tibialis anterior and triceps surae lengthening held along with the contraction (reciprocal inhibition). The G2 apply  electrical muscle activity and resistance to movement after application of neuromuscular electrical stimulation (NMES) in patients with spastic hemiparesis.", 
            "measure": "Analysis of the electrical muscle activity and resistance to movement after application of neuromuscular electrical stimulation (NMES) in patients with spastic hemiparesis.", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945151"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Universidade do Vale do Para\u00edba", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universidade do Vale do Para\u00edba", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}